Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery



Summary



GlobalData’s new report, “Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides key market data on the Europe Diabetes Care Devices market – Germany, France, Italy, Spain and United Kingdom.. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Countries covered include Germany, France, Italy, Spain and United Kingdom..
- Market size and company share data for Diabetes Care Devices market categories – Insulin Delivery and Glucose Monitoring.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Diabetes Care Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, Becton, Dickinson and Company, Abbott Laboratories, Animas Corporation and Ypsomed Holding AG.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices in Europe 10
3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
3.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices, Europe, Company share (2010-2011) 16
4 Diabetes Care Devices In Germany 18
4.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18
4.2 Diabetes Care Devices, Germany, Distribution Share (2010-2011) 23
4.2.1 Glucose Monitoring, Germany, Distribution Share (2010-2011) 23
4.2.2 Insulin Delivery, Germany, Distribution Share (2010-2011) 23
4.3 Diabetes Care Devices, Germany, Company Share (2010-2011) 24
4.3.1 Diabetes Care Devices, Germany, Company Share (2010-2011) 24
4.3.2 Glucose Monitoring, Germany, Company Share (2010-2011) 26
4.3.3 Insulin Delivery, Germany, Company Share (2010-2011) 28
5 Diabetes Care Devices In France 30
5.1 Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30
5.2 Diabetes Care Devices, France, Distribution Share (2010-2011) 35
5.2.1 Glucose Monitoring, France, Distribution Share (2010-2011) 35
5.2.2 Insulin Delivery, France, Distribution Share (2010-2011) 35
5.3 Diabetes Care Devices, France, Company Share (2010-2011) 36
5.3.1 Diabetes Care Devices, France, Company Share (2010-2011) 36
5.3.2 Glucose Monitoring, France, Company Share (2010-2011) 38
5.3.3 Insulin Delivery, France, Company Share (2010-2011) 40
6 Diabetes Care Devices In United Kingdom 42
6.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42
6.2 Diabetes Care Devices, United Kingdom, Distribution Share (2010-2011) 47
6.2.1 Glucose Monitoring, United Kingdom, Distribution Share (2010-2011) 47
6.2.2 Insulin Delivery, United Kingdom, Distribution Share (2010-2011) 47
6.3 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 48
6.3.1 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 48
6.3.2 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 50
6.3.3 Insulin Delivery, United Kingdom, Company Share (2010-2011) 52
7 Diabetes Care Devices In Italy 54
7.1 Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54
7.2 Diabetes Care Devices, Italy, Distribution Share (2010-2011) 59
7.2.1 Glucose Monitoring, Italy, Distribution Share (2010-2011) 59
7.2.2 Insulin Delivery, Italy, Distribution Share (2010-2011) 59
7.3 Diabetes Care Devices, Italy, Company Share (2010-2011) 60
7.3.1 Diabetes Care Devices, Italy, Company Share (2010-2011) 60
7.3.2 Glucose Monitoring, Italy, Company Share (2010-2011) 62
7.3.3 Insulin Delivery, Italy, Company Share (2010-2011) 64
8 Diabetes Care Devices In Spain 66
8.1 Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66
8.2 Diabetes Care Devices, Spain, Distribution Share (2010-2011) 71
8.2.1 Glucose Monitoring, Spain, Distribution Share (2010-2011) 71
8.2.2 Insulin Delivery, Spain, Distribution Share (2010-2011) 71
8.3 Diabetes Care Devices, Spain, Company Share (2010-2011) 72
8.3.1 Diabetes Care Devices, Spain, Company Share (2010-2011) 72
8.3.2 Glucose Monitoring, Spain, Company Share (2010-2011) 74
8.3.3 Insulin Delivery, Spain, Company Share (2010-2011) 76
9 Overview of Key Companies in Europe Diabetes Care Devices Market 78
9.1 F. Hoffmann-La Roche Ltd. 78
9.1.1 Company Overview 78
9.1.2 Share in the Europe Diabetes Care Devices Market 78
9.2 Sanofi 79
9.2.1 Company Overview 79
9.2.2 Share in the Europe Diabetes Care Devices Market 79
9.3 Novo Nordisk A/S 80
9.3.1 Company Overview 80
9.3.2 Share in the Europe Diabetes Care Devices Market 80
9.4 Eli Lilly and Company 81
9.4.1 Company Overview 81
9.4.2 Share in the Europe Diabetes Care Devices Market 81
9.5 LifeScan, Inc. 82
9.5.1 Company Overview 82
9.5.2 Share in the Europe Diabetes Care Devices Market 82
9.6 Medtronic, Inc. 83
9.6.1 Company Overview 83
9.6.2 Share in the Europe Diabetes Care Devices Market 83
9.7 Bayer HealthCare AG 84
9.7.1 Company Overview 84
9.8 Becton, Dickinson and Company 84
9.8.1 Company Overview 84
9.9 Abbott Laboratories 85
9.9.1 Company Overview 85
9.10 Animas Corporation 85
9.10.1 Company Overview 85
9.11 Ypsomed Holding AG 86
9.11.1 Company Overview 86
9.12 Arkray, Inc. 86
9.12.1 Company Overview 86
9.13 Nipro Corporation 87
9.13.1 Company Overview 87
9.14 B. Braun Melsungen AG 87
9.14.1 Company Overview 87
9.15 Terumo Corporation 88
9.15.1 Company Overview 88
10 Diabetes Care Devices Market Pipeline Products 89
11 Financial Deals Landscape 92
11.1 Partnerships 92
11.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 92
11.1.2 Insulet Amends Licensing Agreement With Abbott Diabetes 93
11.1.3 Mendor Enters Into Distribution Agreement With Merck Serono 94
12 Recent Developments 95
12.1 Strategy And Business Planning 95
12.1.1 Sep 05, 2012: Roche Provides Update On Its Strategy At Investor Conference 95
12.1.2 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 96
12.1.3 Nov 02, 2011: Sanofi To Shut Down RandD Site In Bridgewater, New Jersey 97
12.1.4 Oct 13, 2011: Unisense Establishes US Headquarter 97
12.2 Government and Public Interest 98
12.2.1 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University 98
13 Appendix 100
13.1 Definitions of Markets Covered in the Report 101
13.1.1 Diabetes Care Devices 101
13.2 Research Methodology 102
13.3 Secondary Research 102
13.4 Primary Research 102
13.5 Models 103
13.6 Forecasts 103
13.7 Expert Panels 103
13.8 GlobalData Consulting 104
13.9 Currency Conversion 104
13.10 Contact Us 104
13.11 Disclaimer 104

1.1 List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10
Table 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11
Table 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13
Table 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15
Table 5: Diabetes Care Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011 17
Table 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18
Table 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
Table 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
Table 9: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23
Table 10: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23
Table 11: Diabetes Care Devices, Germany, Company Share, USD Constant, (2010-2011) 25
Table 12: Glucose Monitoring, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 27
Table 13: Insulin Delivery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 29
Table 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30
Table 15: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 32
Table 16: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 34
Table 17: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35
Table 18: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35
Table 19: Diabetes Care Devices, France, Company Share, USD Constant, (2010-2011) 37
Table 20: Glucose Monitoring, France, Company Share by Revenue ($m), USD Constant, 2010-2011 39
Table 21: Insulin Delivery, France, Company Share by Revenue ($m), USD Constant, 2010-2011 41
Table 22: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42
Table 23: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 44
Table 24: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 46
Table 25: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47
Table 26: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47
Table 27: Diabetes Care Devices, United Kingdom, Company Share, USD Constant, (2010-2011) 49
Table 28: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 51
Table 29: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 53
Table 30: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54
Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 56
Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 58
Table 33: Glucose Monitoring, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 34: Insulin Delivery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 35: Diabetes Care Devices, Italy, Company Share, USD Constant, (2010-2011) 61
Table 36: Glucose Monitoring, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 63
Table 37: Insulin Delivery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 65
Table 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66
Table 39: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68
Table 40: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70
Table 41: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
Table 42: Insulin Delivery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
Table 43: Diabetes Care Devices, Spain, Company Share, USD Constant, (2010-2011) 73
Table 44: Glucose Monitoring, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 75
Table 45: Insulin Delivery, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 77
Table 46: Diabetes Care DevicesMarket Pipeline Products 89
Table 47: Insulet Expands Distribution Agreement With Ypsomed Holding 92
Table 48: Insulet Amends Licensing Agreement With Abbott Diabetes 93
Table 49: Mendor Enters Into Distribution Agreement With Merck Serono 94

1.2 List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
Figure 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12
Figure 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14
Figure 5: Diabetes Care Devices, Europe, Company share (%), 2011 16
Figure 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18
Figure 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
Figure 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
Figure 9: Diabetes Care Devices, Germany, Company Share (%), 2011 24
Figure 10: Glucose Monitoring, Germany, Company Share (%), 2011 26
Figure 11: Insulin Delivery, Germany, Company Share (%), 2011 28
Figure 12: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30
Figure 13: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31
Figure 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33
Figure 15: Diabetes Care Devices, France, Company Share (%), 2011 36
Figure 16: Glucose Monitoring, France, Company Share (%), 2011 38
Figure 17: Insulin Delivery, France, Company Share (%), 2011 40
Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42
Figure 19: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 43
Figure 20: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 45
Figure 21: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 48
Figure 22: Glucose Monitoring, United Kingdom, Company Share (%), 2011 50
Figure 23: Insulin Delivery, United Kingdom, Company Share (%), 2011 52
Figure 24: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54
Figure 25: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55
Figure 26: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57
Figure 27: Diabetes Care Devices, Italy, Company Share (%), 2011 60
Figure 28: Glucose Monitoring, Italy, Company Share (%), 2011 62
Figure 29: Insulin Delivery, Italy, Company Share (%), 2011 64
Figure 30: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66
Figure 31: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67
Figure 32: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69
Figure 33: Diabetes Care Devices, Spain, Company Share (%), 2011 72
Figure 34: Glucose Monitoring, Spain, Company Share (%), 2011 74
Figure 35: Insulin Delivery, Spain, Company Share (%), 2011 76
Figure 36: F. Hoffmann-La Roche Ltd., Company Share (%), Europe Diabetes Care Devices Market, 2011 78
Figure 37: Sanofi, Company Share (%), Europe Diabetes Care Devices Market, 2011 79
Figure 38: Novo Nordisk A/S Company Share (%), Europe Diabetes Care Devices Market, 2011 80
Figure 39: Eli Lilly and Company, Company Share (%), Europe Diabetes Care Devices Market, 2011 81
Figure 40: LifeScan, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 82
Figure 41: Medtronic, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 83

Companies mentioned
F. Hoffmann-La Roche Ltd.
Sanofi
Novo Nordisk A/S
Eli Lilly and Company
LifeScan, Inc.
Medtronic, Inc.
Bayer HealthCare AG
Becton, Dickinson and Company
Abbott Laboratories
Animas Corporation
Ypsomed Holding AG
Arkray, Inc.
Nipro Corporation
B

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.